Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Oxidoreductases
Reexamination Certificate
2006-01-24
2006-01-24
Lilling, Herbert J. (Department: 1651)
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Oxidoreductases
C435S181000
Reexamination Certificate
active
06989143
ABSTRACT:
Artificial modulation of ascorbate level was investigated in mice capable of de novo synthesis of ascorbate. When mice were given exogenous ascorbate or its physiological precursor, L-gulono-γ-lactone, the plasma level of ascorbate was elevated substantially but immediately returned to the basal levels. Comparably, the administration of ascorbate oxidase caused a rapid disappearance of plasma ascorbate but followed by an immediate restoration of ascorbate. These results indicate the difficulties encountered in the modulation of ascorbate level in the animal. However, the circulation life of the exogenous ascorbate oxidase in the animal was successfully extended by chemical modification with methoxypolyethylene glycol. The modified enzyme retained a full activity and exerted a remarkably prolonged depletion of plasma ascorbate compared with the native enzyme. This study suggests that the chemically modified ascorbate oxidase should find many uses in the animal studies on ascorbate since it was found to deplete plasma ascorbate even in the ascorbate-synthesizing animal in the absence of dietary control. The enzyme should prove to be useful in tumor control because there are tumor systems in mice and man amenable to the manipulation of ascorbate level.
REFERENCES:
patent: 5834273 (1998-11-01), Futatsugi et al.
patent: 30 43 529 (1982-06-01), None
patent: 011287686 (1989-05-01), None
JPAB Abstract of JP01128786 Published May 22, 1989.
DWPI Abstract of JP01128786 Published May 22, 1989.
Sakagami, et al., “Effect of Ascorbate Oxidase on Radical Intensity and Cytotoxic Activity of Ascorbate”, Anticancer Res., Jan., 1997, 7 (2A), 1163-1166.
Park, et al., “Ascorbic Acid: A Culture Requirement of Colony Formation by Mouse Plasmacytoma Cells”, Science 1764: 720-722, 1971.
Park, “Studies of growth characteristics of myeloma in vitro”, Ph.D. Thesis, University of Toronto, 1971.
Park, et al. “Improved Growth of in Vitro Colonies in Human Acute Leukemia with the Feeding Culture Method”, Cancer Research 37:4595-4601, 1977.
Park, et al, “Analysis of the growth Enhancing Effect of L-Ascorbic Acid on Human Leukemic Cells in Culture”, Exptl Hematol 8:853-859, 1980.
Park, et al, “In Vitro Growth Modulation by L-Ascorbic Acid of Colony-forming Cells from Bone Marrow of Patients with Myelodysplastic Syndromes”, Cancer Research 52:4458-4466, 1992.
Stadtman, et al., “Reactive Oxygen-Mediated Protein Oxidation in Aging and Disease”, Chem Res Toxicol 10: 485:494, 1997.
Levine, et al., “Does vitamin C having a pro-oxidant effect?” Nature 395:231-232, 1998.
Sakagami, et al., “Modulating Factors of Radial Intensity and Cytotoxic Activity of Ascorbate (Review)”, Anticancer Research 17:3513-3520, 1997.
Sauberlich, et al., “Pharmacology of Vitamin C”, Annu. Rev. Nutr. 14: 371-391, 1994.
Halliwell, et al., “Antioxidant and Prooxidant Properties of Vitamin C”, Paker, L: Fuchs, J., eds. Vitamin C in health and disease, New York: Marcel Dekker Inc., 1997 59-73.
Frei, et al., “Ascorbate is an outstanding antioxidant in human blood plasma”, Proc. Natl. Acad. Sci., 86:6377-6381, 1989.
Niki, “Action of ascorbic acid as a scavenger of active and stable oxygen radicals”, Am J Clin Nutr 1991, 54:1119S-24S.
Mendiratta, et al., “Erythrocyte Ascorbate Recycling: Antioxidant Effects in Blood”, Free Radic. Biol. Med. 24: 789797, 1998.
Bendich, et al., “The Health Effects of Vitamin C Supplementation: A Review”, J. Am. Coll. Nutr. 14: 124-136, 1995.
Block, “Vitamin C Status and Cancer. Epidemiologic Evidence of Reduced Risk”, Ann. NY Acad. Sci., 669: 280-290, 1992.
Bram, et al., “Vitamin C preferential toxicity of Malignant melanoma cells”, Nature, 284: 629-631, 1980.
Riordan, et al, “Intravenous Ascorbate as a Tumor Cytotoxic Chemotherapeutic Agent”, Med. Hypothesis, 44: 207-213, 1995.
Koh, et al., “Differential Effects and Transport Kinetics of Ascorbate Derivatives in Leukemic Cell Lines”, Anticancer Res., 19: 2487-2494, 1998.
Park, et al, “Growth modulation of human leukemic, preleukemic, and myeloma progenitor cells by L-ascorbic acid”, Am. J. Clin. Nutr., 54: 1241S-1246S, 1991.
Tsao, et al., “Effect of Dietary Ascorbic Acid Intake on Tissue Vitamin C in Mice”, J. Nutr., 117: 291-297, 1987.
Jackson, et al., “Synthesis, Isolation and Characterization of Conjugates of Ovalbumin with Monomethoxypolyethylene Glycol Using Cyanuric Chloride as the Coupling Agent”, Anal. Biochem., 165: 114-127, 1987.
Laemmli, “Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4”, Nature, 227: 680-685, 1970.
Kim, et al., “A Heme-containing Ascorbate Oxidase fromPleurotus ostrealtus” J. Biol. Chem., 271: 3105-3111, 1996.
Bánhegyi, et al., “Ascorbate Metabolism and it Regulation in Animals”, Free Radic. Biol. Med., 23: 793-803, 1997.
Nishikimi, et al., “L-Gulono-γ-lactone Oxidase (Rate and Goat Liver)”, Methods Enzymol., 62: 24-30, 1979.
Nishikimi, et al.Cloning and Chromosocmal Mapping of the Human Nonfunctional Gene for L-Gulono-γ-lactone Oxidase, the Enzyme for L-Ascorbic Acid Biosynthesis Missing in Man, J. Biol. Chem., 269: 13685-13688, 1994.
Braun, et al., “Ascorbate as a Substrate for Glycolysis or Gluconeogenesis: Evidence for an Interorgan Ascorbate Cycle”, Free Radic. Bil. Med., 23: 804-808, 1997.
Tsao, et al., “Effect of Exogenous Ascorbic Acid intake on Biosynthesis of Ascorbic Acid in Mice”, Life Sci., 45: 1553-1557, 1989.
Lee, et al., “Axcorbate Oxidase”, Methods Enzymol., 62: 30-39, 1979.
Stevanato, et al., “Determinationof Ascorbic Acid with Immobilizd Green Zucchini Ascorbate Oxidase”, Anal. Biochem, 149: 537-542, 1985.
Himmelrcich, et al., “C NMR Studies of Vitamin C Transport and its Redox Cycling in Human Erythrocytes”, Biochemistry, 37: 7578-7588, 1998.
Abuchowski, et al., “Effect of Covalent Attachment of Polyethylene Glycol on Immunogenicity and Circulating Life of Bovine Liver Catalase”, J. Bio. Chem., 252: 3582-3586, 1977.
Duncan, et al., Polymer Conjugates. Pharmacokinetic Considerations for Design and Development, Clin. Pharmacokinet, 27: 290-306, 1994.
Koshiishi et al., “Degredation of dehydroascorbate to 2,3-diketogulonate in blood circulation”, Biochim. Biophys. Acta., 1425: 209-214, 1998.
Boo Yong C.
Park Chan Hyung
Jin Yang Pharm Co., Ltd.
Lilling Herbert J.
Merchant & Gould P.C.
Park Chan Hyung
LandOfFree
Depletion method of blood plasma ascorbate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Depletion method of blood plasma ascorbate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Depletion method of blood plasma ascorbate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3603428